The recommended age to start colonoscopy screening is 45 for adults at average risk of colorectal cancer. This changed in recent years: until 2018, most guidelines set the starting age at 50. The American Cancer Society lowered its recommendation to 45 in 2018, and the U.S. Preventive Services Task Force followed in 2021. If you have a family history of colorectal cancer or certain genetic conditions, you may need to start much earlier.
Why the Starting Age Dropped to 45
For decades, age 50 was the standard. That changed because colorectal cancer rates have been climbing steadily in younger adults. The American Cancer Society updated its guideline in 2018, recommending that all average-risk people begin screening at 45. The USPSTF made the same change in 2021, giving the recommendation for ages 45 to 49 a “B” grade, meaning there is moderate certainty of a meaningful benefit. For adults 50 to 75, the evidence is even stronger, earning the highest “A” grade.
This shift matters for insurance coverage too. The Affordable Care Act requires private insurers and Medicare to cover colorectal cancer screening tests recommended by the USPSTF with no out-of-pocket costs like co-pays or deductibles. That means a screening colonoscopy at age 45 is typically free. One important caveat with Medicare: if a polyp is found and removed during the procedure, Medicare may charge a 15% co-insurance and a co-pay, since it reclassifies the test from “screening” to “diagnostic.” Private insurance generally covers polyp removal as part of the screening without extra charges.
When to Start Earlier: Family History
If colorectal cancer runs in your family, age 45 is likely too late to begin screening. The general rule is to start at 40, or 10 years before the youngest family member was diagnosed, whichever comes first. Here’s how it breaks down:
- One first-degree relative (parent, sibling, or child) diagnosed after age 60: Start screening at age 40.
- One first-degree relative diagnosed before age 60, or two first-degree relatives diagnosed at any age: Start at age 40 or 10 years before the earliest diagnosis in the family.
- A first-degree relative with an adenomatous polyp diagnosed after age 60: Starting at 40 is also reasonable.
These aren’t edge cases. Roughly one in four people with colorectal cancer has a family member who also had the disease. If you’re unsure about your family history, it’s worth asking relatives directly, since many people don’t know about cancers in their extended family until they start asking.
Genetic Conditions That Require Early Screening
Certain inherited conditions dramatically increase colorectal cancer risk and call for screening to begin in early adulthood. Lynch syndrome is the most common. People with Lynch syndrome are advised to begin colonoscopy between ages 20 and 25, or two to five years before the youngest cancer diagnosis in the family if that happened before age 25. The screening interval is also much more frequent: every one to two years rather than every 10.
Familial adenomatous polyposis (FAP) is another inherited condition that typically requires screening to start in the teenage years. These conditions are relatively rare, but if your family has a known genetic syndrome or a pattern of multiple cancers at young ages, genetic testing and earlier surveillance are standard practice.
How Often You Need a Colonoscopy After the First One
If your first colonoscopy comes back completely clean with no polyps, the standard interval is 10 years before your next one. That means someone who starts at 45 and has a normal result wouldn’t need another colonoscopy until age 55.
If polyps are found and removed, the timeline shortens. Small, low-risk polyps typically mean a follow-up in five to seven years. Larger polyps, multiple polyps, or polyps with concerning features under the microscope may call for a repeat in three years. Your gastroenterologist will set the specific interval based on what they find.
When to Stop Screening
The USPSTF recommends routine screening through age 75. Between ages 76 and 85, the decision becomes individual. Factors like your overall health, life expectancy, and whether you’ve been screened regularly before all play a role. Someone who has had consistent clean screenings and is in good health might reasonably stop, while someone who has never been screened might still benefit. After 85, screening is generally not recommended.
Screening Is Not Just for People With Symptoms
Colonoscopy screening exists specifically because colorectal cancer often produces no symptoms in its early, most treatable stages. That said, certain warning signs can appear well before a diagnosis, even in people under 45.
A study from the National Cancer Institute found four signs that showed up three months to two years before a colorectal cancer diagnosis in younger adults: abdominal pain, rectal bleeding, diarrhea, and iron deficiency anemia. Having just one of these was associated with nearly double the likelihood of an eventual diagnosis. Having three or more was linked to six times the likelihood. These symptoms don’t automatically mean cancer, but they do warrant a diagnostic colonoscopy regardless of your age. Screening guidelines are about when to look if nothing seems wrong. If something does seem wrong, age thresholds don’t apply.
Other Screening Options Besides Colonoscopy
Colonoscopy is the most thorough screening method, but it’s not the only one. Stool-based tests can detect blood or altered DNA shed by polyps and cancers. These are less invasive and done at home, but they need to be repeated more frequently (annually for some tests, every three years for others) and a positive result still requires a follow-up colonoscopy.
CT colonography, sometimes called a virtual colonoscopy, uses imaging instead of a scope and is recommended every five years. All of these options are covered under the same insurance rules when used for screening. The best screening test is the one you’ll actually complete. If the prep and sedation involved in a traditional colonoscopy feel like a barrier, a stool-based test is a legitimate alternative that catches the majority of cancers.